About
We’re celebrating 20 years of the Non-Dilutive Funding Summit!
Join us at the 20th annual NDFS, a free, educational event helping life science executives acquire valuable information about non-dilutive funding opportunities for life science R&D.
Come together with hundreds of other innovators in the life science industry to hear the authorities at funding agencies like NIH, BARDA, DoD, and more, discuss their research funding priorities, their variety of funding programs, application processes, submission tips, and more.
Links to Recordings & Slides Below
Agenda
Coming Soon! Confirmed speakers include:
Dr. Rajesh Kumar
Program Officer
NIA (National Institute on Ageing)
Dr. Shyam Patel
Senior Director of Business Development and Alliance Management
CIRM (California Institute for Regenerative Medicine)
Dr. Natalia Kruchinin
Program Coordinator, Team Lead
NIAID (National Institute of Allergy and Infectious Diseases)
Dr. Sagar Ghosh
Program Manager
CDMRP (Congressionally Directed Medical Research Programs)
Dr. Amie D. Bunker
Program Manager
CDMRP (Congressionally Directed Medical Research Programs)
Joe Buccina
Director, Policy and Research
NSCEB (National Security Commission on Emerging Biotechnology)
Speaker TBD
CEPI (Coalition for Epidemic Preparedness Innovations)
Dr. Michael Koeris
Office Director, Biological Technologies Office
DARPA (Defense Advanced Research Projects Agency)
Dr. Mike Stebbins
Senior Vice President
ATI (Advanced Technology International)
Dr. Stephanie Davis
Small Business Program Coordinator
NHLBI (National Heart, Lung, and Blood Institute)
Alan Chiu
Research Scientist
Breakthrough T1D
**The Non-Dilutive Funding Summit is a purely educational event and does not constitute an endorsement from any of the Funding Agencies presenting
Opportunity for 1×1 Meetings
Take advantage of the opportunity to meet 1×1 with representatives from leading funding agencies as well as meeting 1×1 with the FreeMind Group Business Development team to discuss what non-dilutive funding opportunities are available to fund your R&D.